The promoter of the murine JS-rus proto-oncogene contains a (C+G)-rich homopurine . homopyrimidine (R . Y) sequence that is essential for transcription activity. We have designed two G-rich oligonucleotides, d(TGGGTGGGTGGTTGGGTGGG) (20GT) and d(AGGGAGGGAGGAAGGGAGGG) (20AG), that have the potential to bind the critical Ki-rus sequence via tripIex-helix formation. Band-shift experiments have shown that 20GT binds the Ki-rus R . Y duplex with a AG value of -40 -t 5 kJ/mol, while 20AG appeared to have a lower affinity under the experimental conditions adopted: 50 mM Tris/HCI, pH 7.4, 50 inM NaC1, 5 mM MgCl,, 25°C. In the absence of Mg2+, 20GT did not bind to the Ki-rus R . Y target, while 20AG exhibited the same affinity observed in the magnesium-containing buffer. To gain insight into the solution properties of 20GT and 20AG, we have performed several experiments including polyacrylamide gel electrophoresis (PAGE), hydroxyapatite chromatography, ultraviolet absorption melting and circular dichroism (CD). We found that 20AG rapidly self-associates into presumably a duplex, even at low concentration (< 1 pM), while 20GT forms aggregates slowly, a process favoured by high oligonucleotide concentrations (> 25 pM). The critical Ki-rus sequence was inserted in Bluescript KS+, downstream from the T7 promoter, to investigate to what extent 20AG and 20GT, which are directed against the R . Y target, are able to inhibit T7 RNA polymerase transcription, under nearphysiological conditions. Transcription experiments conducted in vitro at pH 7.4 have shown that oligonucleotide 20GT produced a remarkable repression of T7 RNA polymerase activity in the concentration range (10-25 pM), whereas 20AG had little effect on transcription. In conclusion, the results of this work together with other data reported in the literature